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Abstract Herein we describe the inhibitory effect of the esterification, catalyzed by lecithin-cholesterol acyltransferase 
synthetic peptide A[~I-40, homologous to the major high-density (LCAT, EC 2.3.1.4.3) [9]. Association of sA[~ with HDL sug- 
lipoprotein-associated species of Alzheimer's amyloid [~ protein gests that it may have some function(s) in lipid metabolism, as 
(A[~), on lipid biosynthesis in human hepatic HepG2 cells. This do many other apolipoproteins [10]. This possibility is 
culture synthesizes various lipids from [14C]acetate as a strengthened by our recent observation of the inhibition of 
precursor. Treatment of cells with different concentrations of normal human plasma cholesterol esterification by Alzhei- 
A[~l-40 decreased the syntheses of various radiolabeled lipid mer's peptides A~l-40 and A[~1-28 [6,11]. 
species. The decrease reached saturation at peptide coneentra- All this prompted us to elucidate whether AI3 protein has 
tions equal to 10-100 ng ml - l .  The lipids whose synthesis was other functions in lipid metabolism, in particular, whether it 
decreased most were free and esterified cholesterol and affects cellular lipid synthesis. Hepatic cells in culture have 
pbospholipids. This inhibitory effect suggests that AI5 protein provided a useful model to study the effects of different com- 
may modulate physiological intracellular fipid syntheses. It may 
also be of special importance in the pathological condition, and pounds on lipid metabolism [12,13] without interference from 
contribute to the neurodegeneration, i  Alzheimer's disease and the other tissues (vascular, adipose, etc.). In this paper, we 
related disorders, report on the effects of Alzheimer's peptide A[~l-40 on hepat- 
ic lipid syntheses using a hepatocellular carcinoma derived 
Key words." Amyloid beta protein; Apolipoprotein; HepG2 cell line [14] as model. The results show that A~I -  
Alzheimer's disease; Down's syndrome; Lipid biosynthesis; 40 treatment decreases the synthesis of lipids, in particular 
Lipoprotein free and esterified cholesterol and phospholipids, in HepG2 
cells. These data may help further understanding of the nor- 
mal biology of sA[3 and the mechanism of neurodegeneration 
1. Introduction in Alzheimer's brain. 
Amyloid ]3 (A~), a proteolytic product of the amyloid pre- 
cursor protein ([3PP), is a hydrophobic peptide of 39-44 ami- 2. Materials and methods 
no acids, which was long considered the only pathologic pro- All reagents unless otherwise specified were purchased from Sigma. 
tein, composing the amyloid plaques and cerebrovascular Human serum albumin (HSA) was essentially fatty acid free. Petro- 
amyloid in Alzheimer's disease (AD), Downs' syndrome leum ether was from Fisher Scientific. Synthetic peptide A[~I-40 was 
(DS) and related disorders. Nevertheless, in 1992, it was found synthesized at the W.M. Keck Facility at Yale University and repur- 
as a soluble component (sA[3) in plasma and cerebrospinal ified as previously described [11]. 
HepG2 human hepatocellular carcinoma cell line was obtained 
fluid (CSF) of both normal and AD patients, as well as in from the American Type Culture Collection (Rockville, MD). Cells 
many cell cultures' supernatants (for a review see [1]). were grown on 6-well cell culture plates (35 mm diameter well) in 
Furthermore, the A[~ sequence appears to be highly conserved Dulbecco's modified Eagle's medium supplemented with 10% fetal 
in eukaryotes [2-4], while [~PP mRNA is expressed in many bovine serum (FBS) and 6.99 mM L-glutamine. All cell cultivations 
species [1]. These facts suggest hat A[~ is involved in some and incubations were performed at 37°C in a humidified incubator 
with 5% CO2-95% air. For passage, cells were harvested with 0.25% 
basic metabolic pathways, trypsin and 1 mM EDTA. Experiments were started when cell mono- 
Our studies yielded experimental evidence of sA[~ associa- layers became 90% confluent. Cell morphology and ultrastructure 
tion with high density lipoproteins (HDL) in both normal were monitored by transmissional electron microscopy as previously 
human plasma [5] and CSF [6,7]. These are the most dense described [15]. The absence of staining with fluorescein diacetate was 
used as the criterion for cell viability [16]. lipoprotein complexes, which carry out important functions in To assess lipid syntheses, cells in culture were labeled with 0.1 ~Ci 
lipid metabolism [8]. 'One of these functions is the crucial step [14C]acetate (50 mCi/mmol, ICN, USA) per well in 0.5 ml of FBS-free 
of reverse cholesterol transport, the reaction of cholesterol medium [17]. Labeling was performed without A[3 peptide (control) 
and in the presence of the peptide at different concentrations (0.5, 1.0, 
5.0, 10.0, 100.0 and 500.0 ng ml-1). Labeling was also performed with 
*Corresponding author. Department of Biochemistry, Russian HSA at the concentrations specified. After 3 h of incubation, the 
Peoples' Friendship University School of Medicine, Miklucho-Maklay cultures were rinsed three times with 2 ml of FBS-free medium and 
St. 8, Moscow 117198, Russia. Fax: (7) (095) 246-2690/246-7446, re-fed with 0.75 ml of medium without radioactive precursor. After 24 
c/o Dmitri B. Kalugin. E-mail: koudin@imb.imb.ac.ru h incubation, the monolayers were washed three times with cold phos- 
phate-buffered saline, pH 7.3 and the intracellular lipids were ex- 
Abbreviations." A[~, amyloid beta; AD, Alzheimer's disease; CSF, tracted and analyzed as described below. 
cerebrospinal fluid; DS, Down's syndrome; FBS, fetal bovine serum; Extraction of intracellular lipids was performed irectly from cell 
HDL, high density lipoprotein; HSA, human serum albumin; sA[3, monolayers on the 6-well plates. Intracellular lipids were extracted 
soluble form of A]3; TLC, thin-layer chromatography three times for 30 min at 25°C with 300 ~tl of hexane/isopropanol 
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(3:2, v/v) [18]. The solvent phases were combined and then dried , 100- 
under a stream of nitrogen and resuspended in 50 gl of hexane. --. A 
Extracted intracellular lipids were separated by thin-layer chroma- 
tography (TLC) [19] on silica gel G TLC plates (Whatmann, USA) in • 
a solvent system of petroleum ether-diethyl ether-acetic acid (70:30:1, .O * 
v/v) and located by exposure to iodine vapor. The areas correspond- "~'~ l l ~  , , l ~  
ing to authentic lipid standards were placed in scintillation vials with ~- o *** *** 
2 ml of BetaMax scintillation fluid (ICN, USA) and counted. O o 75- en~ For protein content determination, cell monolayers after lipid ex- 
tractions were solubilized in 0.5 ml/well of 0.2 N NaOH for 16 h at "~ 
room temperature [20]. Protein content in aliquots of solubilized cells 
was quantitated using a commercially available kit from Bio-Rad. O 
Bovine serum albumin, 2 mg/ml water solution (Pierce, USA), was 
used as a standard for the calibration curve. 0.5 1.0 5.0 10.0 100.0 500.0 
The intracellular synthesis of each lipid class (phospholipids, unes- AI~ 1-40, nglml 
terified and esterified cholesterol, and triacylglycerols) was expressed 
as lipid-incorporated 14C radioactivity (cpm) per I.tg of cell protein 
and represents mean+SEM, n=9. Each experimental point was a 
mean of four repeats. For the tested concentrations of A[~IM0 and 
HSA the data were expressed as a percentage of control (no peptide/ , 100- B 
protein) change in 14C radioactivity (cpm) incorporation i to specific 
lipid classes per gg of cell protein. * * / f ree  cholesterol 
Non-parametric Wilcoxon signed rank test was used for determin- ~ i i i l l  ['-"7~i *~Q ~*  ing significant differences between lipid synthesis in the presence of ~ ** cholesterol esters 
A~ll~,0 and without it [21]. A probability of 0.05 or less was accepted - -  
as statistically significant. , ,  
75 ***  ***  
3. Results and discussion *T* 
To assess whether A[~ protein affects cellular lipid synthesis 
we used hepatic HepG2 cells. These are cells commonly used 0.5 1.0 5.0 10.0 100.0 500.0 
for l~pid and lipoprotein metabolism and lipid synthesis tud- AI~ 1-40, nglml 
ies [14,22]. Intracellular lipid synthesis was traced by the in- 
corporation of [14C]acetate radioactivity into the newly 
synthesized phospholipids, free and esterified cholesterol and 
triacylglycerol in the presence of different amounts of AI31~0, ~ 100- L C 
shown to be the major form of HDL-associated sA[3 protein ~, 
[6,7]. The control values (no peptide added) for [14C]acetate 2 
radioactivity incorporation (cprrdgg of cell protein) into dif- -- 
ferent lipid classes under our experimental conditions were: o o * 
18.54 + 0.45 for phospholipids, 0.954 + 0.059 and 0.534 + 0.025 o ° 
for free and esterified cholesterol, respectively, and 7.63 + 0.42 ~*~ **" 
for triacylglycerol. "~ 
AI31~0 inhibited multiple intracellular lipid syntheses, in ~ 75- 
particular the syntheses of phospholipids (Fig. 1A), free and _ _ 
esterified cholesterol (Fig. 1B), and triacylglycerol (Fig. 1C), 0.5 1.0 5.0 10.0 100.0 500.0 
while HSA used as a control did not affect the syntheses with- AI$140, nglml 
in the tested concentration range. The inhibitory effect was 
concentration dependent and reached saturation at 10-100 Fig. 1. Effect of A[31~0 on the incorporation of [14C]acetate into 
phospholipids (A), cholesterol (B), and triacylglycerols (C) in 
ng of the peptide per ml of culture media, although cytotoxic HepG2 cells. The incorporation of [14C]acetate was determined after 
effects were not found for any tested A~l-40 concentration extraction of lipids and their separation by TLC. Values are 
within the incubation period of 3 h. The inhibitory effects of mean _+ SEM, n = 9. Each experimental point is the mean of four re- 
Al31-40 were also statistically significant at concentrations peats. Asterisks indicate significant differences with respect o con- 
trol (no peptide added) values (100%): *P<0.02; **P<0.008; 
lower than 10 ng m1-1. This may well reflect physiological ***p<0.001, one-tailed. HSA as a control did not affect the incor- 
modulation of lipid metabolism by AI3 protein and represent poration of [14C]acetate into HepG2 lipids. 
one of the lipid related functions of sAI3 as an apolipoprotein 
constituent of HDL [5-7]. On the other hand, the high con- 
centrations of A~ peptide (100 and 500 ng m1-1) also studied maximum inhibition, Fig. 1B) and phospholipid (25% maxi- 
herein are not likely to be reached under physiological condi- mum inhibition, Fig. 1A) would clarify the cholesterol to 
tions, but may well represent the local tissue environment in phospholipid mole ratio decrease in the AD temporal gyrus 
AD brain. If the inhibitory effects of A~ protein, reported versus age-matched controls, observed previously [26]. Our 
here in the model of HepG2 cells of hepatic origin, similarly data thus extend current knowledge [23-26], providing a pos- 
take place in the brain tissue, it would suggest an explanation sible biochemical explanation for membrane destabilization 
of the reported changes in lipid composition in specifc brain secondary to a lipid compositional berration as a mechanism 
regions in AD [23 25]. In addition, the differences in the el'- for Al3-dependent eurodegeneration in AD. 
fects of A[3 on the metabolism of unesterified cholesterol (40% Nevertheless, the question of what is the primary event for 
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this purported cascade remains obscure. Induction of AI3 im- [8] Klimov, A. and Nikulcheva, N. (1994) in: Lipids, Lipoproteins 
and Atherosclerosis, pp. 95-153, Piter, St. Petersburg. 
munoreactivity in the brains of rabbits with enriched dietary [9] Fielding, C. and Fielding, P. (1995) J. Lipid Res. 36, 211-228. 
cholesterol [27] suggests, assuming the concentration-depend- [10] Mahley, R., Innerarity, T., Rall, S. and Weisgraber, K. (1984) 
ent inhibitory effect of A[3 protein on lipid biosynthesis re- J. Lipid Res. 25, 1277-1294. 
ported here, that an increase in AI3 concentration within the [11] Koudinov, A., Koudinova, N. and Berezov, T. (1996) Biochem. 
affected brain tissue might be secondary, and due to prior Mol. Biol. Int. 38, 74~752. 
[12] Marsh, J. (1986) Methods Enzymol. 128, 489-518. 
changes in lipid metabolism, particularly of cholesterol. [13] Berezov, T. and Korovkin, B. (1992) in: Biochemistry, pp. 257- 
Such induction of A[3 deposition [27] may also be the case 294, Mir, Moscow. 
in subjects, carrying the E4/E4 allele of apoE, shown to have [14] Javitt, N. (1990) FASEB J. 4, 161-168. 
elevated plasma cholesterol levels [28,29]. [15] Monaghan, P., Robertson, D. and Beesley, J. (1993) in: Immu- 
Our results show that A[31-40 reduced the incorporation of nocyto-chemistry. A Practical Approach (Beesley, J. ed.) pp. 4- 
76, Oxford University Press, New York. 
[14C]acetate into newly synthesized intracellular lipids of cul- [16] Rotman, B. and Papaermaster, B. (1966) Proc. Natl. Acad. Sci. 
tured HepG2 cells. Since this is a steady-state measurement, USA 55, 134-137. 
the observed effect may also be due to A131-40 mediated in- [17] Mendoza-Figueroa, T. Hernandez, A., De Lourdes Lopez, M. 
crease in lipid catabolism. Further studies are needed to clar- and Kuri-Harcuch, W. (1988) Toxicology 52, 273 286. 
[18] Hara, A. and Radin, N. (1978) Anal. Biochem. 90, 420M26. 
ify the actual mechanism of such an AI3 effect. This is espe- [19] Skipski, V. and Barclay, M. (1969) Methods Enzymol. 14, 442- 
cially important in terms of reported increase of phospholipid 457. 
catabolism in AD brain tissue [30]. Further discussion of A[3 [20] Koudinova, N. (1992) Studies of Atherogenic Effect of Sulfonyl- 
involvement in the lipid turnover and the other consequences ureas, p. 34, Russian State Medical University, Moscow. 
of sAl3 association with HDL will be forthcoming. [21] Zanina, E. (1990) Methods of Statistical Analysis Handbook, 
Pirogov Second Medical Institute, Moscow. 
[22] Wang, S., Pessah, M., Infante, J., Catala, D., Salvat, C. and 
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